Prosight Management, LP
DALLAS, TX · CIK 1617201 · 13F filing filed 2026-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityPROSIGHT MANAGEMENT, LP (US)
$580.4m
reported value
-4.8% vs Q1 2026
36positions
70.7%in top 10
5 new
16 added
15 reduced
15 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| GALAPAGOS NV LKFT | $61.3m10.56% | Added +493.3k |
| JANUX THERAPEUTICS INC JANX | $58.4m10.07% | Added +254.5k |
| NEKTAR THERAPEUTICS NKTR | $56.5m9.74% | Added +75.0k |
| BOSTON SCIENTIFIC CORP BSX | $54.2m9.34% | Added +474.7k |
| SHATTUCK LABS INC STTK | $41.3m7.12% | Added +953.4k |
| INSMED INC INSM | $40.0m6.90% | New |
| ALNYLAM PHARMACEUTICALS INC ALNY | $29.5m5.09% | Added +22.1k |
| SYNDAX PHARMACEUTICALS INC SNDX | $26.2m4.52% | Added +430.0k |
| KURA ONCOLOGY INC KURA | $22.2m3.82% | Reduced -1.3m |
| ALKERMES PLC ALKS | $20.7m3.56% | Reduced -119.2k |
| IRHYTHM TECHNOLOGIES INC IRTC | $19.7m3.39% | Added +155.5k |
| VEEVA SYS INC VEEV | $18.8m3.25% | Added +19.7k |
| ZYMEWORKS INC ZYME | $17.6m3.04% | Added +135.4k |
| ABIVAX SA ABVX | $14.3m2.47% | Added +2.4k |
| CRINETICS PHARMACEUTICALS IN CRNX | $14.0m2.42% | Added +24.7k |
| MINERALYS THERAPEUTICS INC MLYS | $12.1m2.09% | New |
| ADC THERAPEUTICS SA ADCT | $8.4m1.44% | Reduced -475.3k |
| ICU MED INC ICUI | $7.5m1.29% | Added +23.6k |
| INTUITIVE SURGICAL INC ISRG | $6.8m1.16% | Added +13.0k |
| CORBUS PHARMACEUTICALS HLDGS CRBP | $6.1m1.05% | Reduced -47.1k |
| PROCEPT BIOROBOTICS CORP PRCT | $6.1m1.04% | Reduced -1.7m |
| GENEDX HOLDINGS CORP WGS | $5.9m1.01% | Reduced -438.0k |
| OPTION CARE HEALTH INC OPCH | $5.7m0.98% | New |
| ONKURE THERAPEUTICS INC OKUR | $4.5m0.77% | Reduced -1.2m |
| EMERGENT BIOSOLUTIONS INC EBS | $3.9m0.66% | Reduced -179.2k |
| PFIZER INC PFE | $3.3m0.56% | New |
| ORTHOPEDIATRICS CORP KIDS | $3.0m0.52% | Reduced -144.9k |
| ROCKET PHARMACEUTICALS INC RCKT | $2.4m0.41% | Added +16.1k |
| AN2 THERAPEUTICS INC ANTX | $2.3m0.40% | Reduced -41.1k |
| PLIANT THERAPEUTICS INC PLRX | $1.6m0.27% | Reduced -297.4k |
| TECTONIC THERAPEUTIC INC TECX | $1.4m0.24% | Reduced -40.1k |
| MEIRAGTX HLDGS PLC MGTX | $1.2m0.21% | Reduced -2.5m |
| ASGN INC EFOR | $1.2m0.21% | New |
| REIN THERAPEUTICS INC RNTX | $1.1m0.20% | Added +688.4k |
| COYA THERAPEUTICS INC COYA | $994.5k0.17% | Reduced -250.4k |
| IMMUNEERING CORP IMRX | $183.9k0.03% | Reduced -86.5k |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| CONCENTRA GROUP HOLDINGS PAR CON | $10.8m505.8k shares |
| TERNS PHARMACEUTICALS INC | $10.7m202.3k shares |
| PHREESIA INC PHR | $9.2m1.1m shares |
| SCHRODINGER INC SDGR | $5.8m510.6k shares |
| ROIVANT SCIENCES LTD ROIV | $5.0m180.0k shares |
| IMMUNOVANT INC IMVT | $4.4m175.8k shares |
| UPSTREAM BIO INC UPB | $2.2m241.1k shares |
| OMEROS CORP OMER | $1.8m174.8k shares |
| ADICET BIO INC ACET | $1.7m250.2k shares |
| REGENXBIO INC RGNX | $1.7m200.0k shares |
| VIKING THERAPEUTICS INC VKTX | $1.5m45.0k shares |
| TRUEBLUE INC TBI | $974.0k249.1k shares |
| PALVELLA THERAPEUTICS INC NE PVLA | $623.2k5.0k shares |
| NOVOCURE LTD NVCR | $549.4k50.4k shares |
| TRANSMEDICS GROUP INC TMDX | $497.1k5.0k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| SHATTUCK LABS INC STTK · 13G · filed 2025-11-13 | 9.9%≈ $45.4m |
| ADC THERAPEUTICS SA ADCT · 13G · filed 2026-02-13 | 6.8%≈ $9.1m |
| JANUX THERAPEUTICS INC JANX · 13G · filed 2026-02-06 | 5.3%≈ $48.5m |